Related Experiment Video
Updated: Aug 14, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Lipids and lipoproteins in calcific aortic valve disease
Olcay Aksoy1, Yin Tintut1,2,3, Linda L Demer1,2,4
1Department of Medicine.
Insights
Lipoprotein(a) [Lp(a)] plays a key role in calcific aortic valve disease (CAVD), despite disappointing results from traditional lipid-lowering therapies. New diagnostic and therapeutic strategies targeting Lp(a) and other pathways are emerging for CAVD.
Area of Science:
- Cardiovascular Medicine
- Lipidology
- Valvular Heart Disease
Background:
- Lipids and lipoproteins are implicated in calcific atherosclerosis.
- The role of lipids in calcific aortic valve disease (CAVD) is increasingly recognized, with links to hypercholesterolemia and lipoprotein(a) [Lp(a)].
- Despite similarities with atherosclerosis, lipid-lowering therapies have shown disappointing results in CAVD.
Purpose of the Study:
- To review current evidence on the role of lipids and lipoproteins in CAVD.
- To discuss novel diagnostic and therapeutic approaches for CAVD.
- To explore the mechanisms underlying lipid involvement in CAVD.
Main Methods:
- Review of clinical and genetic studies linking lipids, particularly Lp(a), to CAVD.
- Analysis of emerging diagnostic techniques, including lipid droplet visualization and antibody screening.
- Evaluation of novel therapeutic strategies, such as Lp(a) lowering and SGLT2 inhibition.
Main Results:
- Strong evidence supports the role of Lp(a) levels in CAVD.
- Potential diagnostic advances include pH-sensitive probes for lipid droplets and natural antibodies to modified LDL.
- Emerging therapies include Lp(a) lowering, SGLT2 inhibition, and soluble guanylate cyclase reactivation, though trial outcomes are mixed.
Conclusions:
- Recent research clarifies the mechanisms of lipid and Lp(a) contribution to CAVD.
- New diagnostic tools involve screening for natural antibodies and visualizing lipid deposits.
- Novel therapeutic agents like oligonucleotides and nanoparticles are under investigation, with new clinical trials commencing.
Purpose Of Review:
Lipids and lipoproteins have established roles in calcific atherosclerosis, but there is less awareness of their role in calcific aortic valve disease (CAVD). Clinical studies link CAVD with severe hypercholesterolemia, and genetic studies consistently link it with lipoprotein little (a) [Lp(a)], a major carrier of oxidized phospholipids. Given the remarkable similarities between calcific atherosclerotic plaques and calcific aortic valves, lipids are incriminated. Hence, lipid-lowering therapies used for atherosclerosis have been tested in CAVD, but results have been inexplicably disappointing. New evidence for the importance of lipids, despite failure of lipid-lowering, and new concepts in diagnostic and therapeutic approaches are discussed.
Recent Findings:
Evidence supports a key role of Lp(a) levels in CAVD. Potential diagnostic advances include pH-sensitive-fluorescence probes for visualizing lipid droplets in valves and identification of natural antibodies to modified LDL that associate inversely with CAVD. Potential therapeutic advances include Lp(a) lowering, SGLT2 inhibition, and reactivation of soluble guanylate cyclase. Trial outcomes currently remain mixed.
Summary:
Recent studies clarify the mechanisms by which lipids, lipoproteins, and Lp(a) contribute to CAVD. New potential diagnostic techniques include screening for natural antibodies and visualizing lipid deposits. New therapeutic agents include oligonucleotides and nanoparticles. New clinical trials are underway.
Related Concept Videos
Atherosclerosis I: Introduction
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Aortic Regurgitation III: Medical Management
Cholesterol: Significance and Regulation
Considering cholesterol and...

